FDA Inspection 1338630 — Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division)
The FDA completed an inspection of Anhui Haoyuan Pharmaceutical Co., Ltd. (Taodian Avenue Division) on Aug 21, 2026 in Maanshan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 21, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Maanshan (China)